Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZSCAN30 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Zscan30 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | ZSCAN30 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Zscan30 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | ZSCAN30 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Zscan30 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of ZSCAN30 mRNA | CTD | PMID:30047161 | ZSCAN30 | Human | amitrole | decreases expression | ISO | Zscan30 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of ZSCAN30 mRNA | CTD | PMID:30047161 | ZSCAN30 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZSCAN30 5' UTR | CTD | PMID:27901495 | ZSCAN30 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ZSCAN30 mRNA | CTD | PMID:20170705 | ZSCAN30 | Human | bisphenol A | affects expression | ISO | Zscan30 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ZSCAN30 mRNA | CTD | PMID:25181051 | ZSCAN30 | Human | bisphenol F | decreases expression | ISO | Zscan30 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of ZSCAN30 mRNA | CTD | PMID:38685157 | ZSCAN30 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ZSCAN30 mRNA | CTD | PMID:38568856 | ZSCAN30 | Human | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of ZSCAN30 mRNA | CTD | PMID:19549813 | ZSCAN30 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ZSCAN30 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZSCAN30 mRNA | CTD | PMID:29803840 | ZSCAN30 | Human | lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of ZSCAN30 mRNA | CTD | PMID:19921347 | ZSCAN30 | Human | methimazole | decreases expression | ISO | Zscan30 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of ZSCAN30 mRNA | CTD | PMID:30047161 | ZSCAN30 | Human | PCB138 | multiple interactions | ISO | Zscan30 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | ZSCAN30 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of ZSCAN30 mRNA | CTD | PMID:26272509 | ZSCAN30 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN30 mRNA | CTD | PMID:27188386 | ZSCAN30 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ZSCAN30 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of ZSCAN30 mRNA | CTD | PMID:34973136 | ZSCAN30 | Human | silicon dioxide | increases methylation | EXP | | 6480464 | Silicon Dioxide results in increased methylation of ZSCAN30 gene | CTD | PMID:34973136 | ZSCAN30 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ZSCAN30 mRNA | CTD | PMID:34032870 | ZSCAN30 | Human | sodium arsenite | decreases expression | ISO | Zscan30 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of ZSCAN30 mRNA | CTD | PMID:37682722 | ZSCAN30 | Human | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of ZSCAN30 mRNA | CTD | PMID:34973136 | ZSCAN30 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of ZSCAN30 mRNA | CTD | PMID:37042841 | ZSCAN30 | Human | trovafloxacin | increases expression | ISO | Zscan30 (Mus musculus) | 6480464 | trovafloxacin results in increased expression of ZSCAN30 mRNA | CTD | PMID:35537566 | ZSCAN30 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of ZSCAN30 mRNA | CTD | PMID:28818685 | ZSCAN30 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZSCAN30 mRNA | CTD | PMID:23179753 and PMID:26272509 | ZSCAN30 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZSCAN30 mRNA | CTD | PMID:27188386 | |